| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |